title: Eruptive squamous cell carcinomas associated with BRAF-inhibitor therapy in a patient with metastatic melanoma.
authors.affiliation: Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
authors.forename: Navid
authors.initials: N
authors.lastname: Ezra
authors.forename: Omid
authors.initials: O
authors.lastname: Hamid
authors.forename: Daniel
authors.initials: D
authors.lastname: Behroozan
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced*; D005260:Female; D006801:Humans; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors* / Q000235:genetics; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf